Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneo...
Main Authors: | Ricardo Grieshaber-Bouyer, Peter A. Nigrovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00346/full |
Similar Items
-
Neutrophils: Need for Standardized Nomenclature
by: Ellen McKenna, et al.
Published: (2021-04-01) -
Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps
by: Panagiotis Skendros, et al.
Published: (2018-09-01) -
Neutrophils cultured ex vivo from CD34+ stem cells are immature and genetically tractable
by: Claire A. Naveh, et al.
Published: (2024-05-01) -
No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID‐19 disease
by: José Alquicira‐Hernandez, et al.
Published: (2021-01-01) -
<italic toggle="yes">Shigella</italic>-Induced Emergency Granulopoiesis Protects Zebrafish Larvae from Secondary Infection
by: Alexandra R. Willis, et al.
Published: (2018-07-01)